Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 29.11.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
FrNimbus Group AB: Bulletin from the Extraordinary General Meeting in Nimbus Group AB (publ)-Today, on 29 November 2024, an Extraordinary General Meeting in Nimbus Group AB (publ) ("Nimbus Group" or the "Company") was held. The general meeting resolved on subsequent approval of the board of...
► Artikel lesen
FrMainz BioMed NV: Mainz Biomed Announces Stock Split381BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the...
► Artikel lesen
FrInvestec Bank PLC: Half-year Report-Investec Bank plcIncorporated in England and WalesRegistration number 489604LEI: 84S0VF8TSMH0T6D4K848 Unaudited condensed Financial Statements...
► Artikel lesen
FrAbliva AB: Abliva AB Interim Report January - September 20246- Positive Interim Analysis of the FALCON Study Paves the Way for KL1333 Development - Third Quarter SummaryImportant events July - September 2024In July, Abliva announced a positive outcome of the...
► Artikel lesen
FrPatagonia Gold Corp.: Patagonia Gold Third Quarter 2024 Financial Results76VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Patagonia Gold Corp. ("Patagonia" or the "Company") (TSXV: PGDC) announces its financial results for the quarter ended September 30,...
► Artikel lesen
FrPremier American Uranium Inc: Premier American Uranium Announces Management Change102TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Premier American Uranium Inc. ("PUR", the "Company" or "Premier") (TSXV: PUR) (OTCQB: PAUIF) announces that David Suda, President of the Company, has resigned...
► Artikel lesen
FrHalmont Properties Corporation Third Quarter Results82TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- HALMONT PROPERTIES CORPORATION (TSX-V: HMT) ("Halmont" or the "Company") announced today that net income to shareholders for the nine months ended September...
► Artikel lesen
FrCue Biopharma, Inc.: Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)104BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
► Artikel lesen
FrRed White & Bloom Brands Inc.: Red White & Bloom Reports Third Quarter 2024 Financial Results7112024-YTD EBITDA increased to $7.5 million; a twenty-fold improvement compared to 2023-YTD EBITDA of $0.4 million2024-YTD Adjusted EBITDA increased 260% to $9.6 million compared to 2023-YTD of $3.7...
► Artikel lesen
FrTransCode Therapeutics, Inc.: TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split135BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA...
► Artikel lesen
FrFuture Vision II Acquisition Corp. Announces Entering into Merger Agreement with Viwo Technology Inc.631NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Future Vision II Acquisition Corp., (NASDAQ: FVNNU) a publicly traded special purpose acquisition company (the "Future Vision") and Viwo Technology Inc....
► Artikel lesen
FrGlobus Maritime Limited Reports Financial Results for the Third Quarter and Nine-month period ended September 30, 202477GLYFADA, Greece, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Globus Maritime Limited ("Globus", the "Company", "we", or "our") (NASDAQ: GLBS), a dry bulk shipping company, today reported its unaudited consolidated...
► Artikel lesen
FrVerve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)112BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on November 29,...
► Artikel lesen
FrAtlantic Petroleum P/F: Atlantic Petroleum - Condensed Consolidated Interim Report - 3rd Quarter 2024217Tórshavn, Faroe Islands, 2024-11-29(GLOBE NEWSWIRE) -- P/F Atlantic Petroleum (NASDAQ Copenhagen: ATLA DKK) today posts its 3rd quarter results for 2024. This announcement should be read in conjunction...
► Artikel lesen
FrInteroil Exploration & Production ASA: Report for the third quarter 2024264November 29, 2024Highlights in the period Interoil's total operated production for the first nine months of 2024 was 551,140 barrels of oil equivalent (boe), a decrease from 698,659 boe in the same...
► Artikel lesen
FrMars Acquisition Corp. Announces Adjournment of Extraordinary General Meeting and Extension of Redemption Deadline362NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Mars Acquisition Corp. (the "Company" or "Mars") (Nasdaq: MARX), a special purpose acquisition company, today announced that the extraordinary general meeting...
► Artikel lesen
Fr89bio, Inc.: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)51SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization...
► Artikel lesen
FrValoe Oyj: Valoe Corporation Business Review January - September 2024175Valoe Oyj Business review 29 November 2024 at 20.20 THE THIRD QUARTER OF 2024 IN BRIEF Financial situation In July-September 2024,...
► Artikel lesen
FrPolyPid Ltd.: PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders' Equity Non-Compliance1.119PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced...
► Artikel lesen
FrFate Therapeutics, Inc.: Fate Therapeutics Announces Leadership Transition417Bob Valamehr, Ph.D. MBA, To Become President and CEO January 1, 2025 Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN...
► Artikel lesen
Seite:  Weiter >>